These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1201 related items for PubMed ID: 29422214
1. Evidence-based national guidelines for the management of suspected fetal growth restriction: comparison, consensus, and controversy. McCowan LM, Figueras F, Anderson NH. Am J Obstet Gynecol; 2018 Feb; 218(2S):S855-S868. PubMed ID: 29422214 [Abstract] [Full Text] [Related]
2. Fetal growth restriction and intra-uterine growth restriction: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians. Vayssière C, Sentilhes L, Ego A, Bernard C, Cambourieu D, Flamant C, Gascoin G, Gaudineau A, Grangé G, Houfflin-Debarge V, Langer B, Malan V, Marcorelles P, Nizard J, Perrotin F, Salomon L, Senat MV, Serry A, Tessier V, Truffert P, Tsatsaris V, Arnaud C, Carbonne B. Eur J Obstet Gynecol Reprod Biol; 2015 Oct; 193():10-8. PubMed ID: 26207980 [Abstract] [Full Text] [Related]
3. Society for Maternal-Fetal Medicine Consult Series #52: Diagnosis and management of fetal growth restriction: (Replaces Clinical Guideline Number 3, April 2012). Society for Maternal-Fetal Medicine (SMFM). Electronic address: pubs@smfm.orgSociety for Maternal-Fetal Medicine, 409 12 St. SW, Washington, DC 20024, USA. pubs@smfm.org., Martins JG, Biggio JR, Abuhamad A. Am J Obstet Gynecol; 2020 Oct; 223(4):B2-B17. PubMed ID: 32407785 [Abstract] [Full Text] [Related]
4. Clinical Opinion: The diagnosis and management of suspected fetal growth restriction: an evidence-based approach. Lees CC, Romero R, Stampalija T, Dall'Asta A, DeVore GA, Prefumo F, Frusca T, Visser GHA, Hobbins JC, Baschat AA, Bilardo CM, Galan HL, Campbell S, Maulik D, Figueras F, Lee W, Unterscheider J, Valensise H, Da Silva Costa F, Salomon LJ, Poon LC, Ferrazzi E, Mari G, Rizzo G, Kingdom JC, Kiserud T, Hecher K. Am J Obstet Gynecol; 2022 Mar; 226(3):366-378. PubMed ID: 35026129 [Abstract] [Full Text] [Related]
5. Diagnosis and surveillance of late-onset fetal growth restriction. Figueras F, Caradeux J, Crispi F, Eixarch E, Peguero A, Gratacos E. Am J Obstet Gynecol; 2018 Feb; 218(2S):S790-S802.e1. PubMed ID: 29422212 [Abstract] [Full Text] [Related]
6. Fetal Growth Restriction: A Comprehensive Review of Major Guidelines. Giouleka S, Tsakiridis I, Mamopoulos A, Kalogiannidis I, Athanasiadis A, Dagklis T. Obstet Gynecol Surv; 2023 Nov; 78(11):690-708. PubMed ID: 38134339 [Abstract] [Full Text] [Related]
7. Does low-molecular-weight heparin influence fetal growth or uterine and umbilical arterial Doppler in women with a history of early-onset uteroplacental insufficiency and an inheritable thrombophilia? Secondary randomised controlled trial results. Abheiden C, Van Hoorn ME, Hague WM, Kostense PJ, van Pampus MG, de Vries J. BJOG; 2016 Apr; 123(5):797-805. PubMed ID: 26036190 [Abstract] [Full Text] [Related]
8. Doppler ultrasound of umbilical and middle cerebral artery in third trimester small-for-gestational age fetuses to decide on timing of delivery for suspected fetal growth restriction: A cohort with nested RCT (DRIGITAT). Marijnen MC, Kamphof HD, Damhuis SE, Smies M, Leemhuis AG, Wolf H, Gordijn SJ, Ganzevoort W, DRIGITAT Trial Group. BJOG; 2024 Jul; 131(8):1042-1053. PubMed ID: 38498267 [Abstract] [Full Text] [Related]
9. An abnormal cerebroplacental ratio (CPR) is predictive of early childhood delayed neurodevelopment in the setting of fetal growth restriction. Monteith C, Flood K, Pinnamaneni R, Levine TA, Alderdice FA, Unterscheider J, McAuliffe FM, Dicker P, Tully EC, Malone FD, Foran A. Am J Obstet Gynecol; 2019 Sep; 221(3):273.e1-273.e9. PubMed ID: 31226291 [Abstract] [Full Text] [Related]
11. Reduced growth velocity from the mid-trimester is associated with placental insufficiency in fetuses born at a normal birthweight. Kennedy LM, Tong S, Robinson AJ, Hiscock RJ, Hui L, Dane KM, Middleton AL, Walker SP, MacDonald TM. BMC Med; 2020 Dec 24; 18(1):395. PubMed ID: 33357243 [Abstract] [Full Text] [Related]
12. Study protocol for a randomized trial on timely delivery versus expectant management in late preterm small for gestational age pregnancies with an abnormal umbilicocerebral ratio (UCR): the DRIGITAT study. Smies M, Damhuis SE, Duijnhoven RG, Leemhuis AG, Gordijn SJ, Ganzevoort W. Trials; 2022 Aug 01; 23(1):619. PubMed ID: 35915472 [Abstract] [Full Text] [Related]
13. The hemodynamics of late-onset intrauterine growth restriction by MRI. Zhu MY, Milligan N, Keating S, Windrim R, Keunen J, Thakur V, Ohman A, Portnoy S, Sled JG, Kelly E, Yoo SJ, Gross-Wortmann L, Jaeggi E, Macgowan CK, Kingdom JC, Seed M. Am J Obstet Gynecol; 2016 Mar 01; 214(3):367.e1-367.e17. PubMed ID: 26475425 [Abstract] [Full Text] [Related]
14. Outcome in early-onset fetal growth restriction is best combining computerized fetal heart rate analysis with ductus venosus Doppler: insights from the Trial of Umbilical and Fetal Flow in Europe. Frusca T, Todros T, Lees C, Bilardo CM, TRUFFLE Investigators. Am J Obstet Gynecol; 2018 Feb 01; 218(2S):S783-S789. PubMed ID: 29422211 [Abstract] [Full Text] [Related]
15. Risk of adverse perinatal outcomes in pregnancies with "small" fetuses not meeting Delphi consensus criteria for fetal growth restriction. Powel JE, Chavan NR, Zantow EW, Bialko MF, Farley LG, McCormick KM, Tomlinson TM. Am J Obstet Gynecol; 2023 Oct 01; 229(4):447.e1-447.e13. PubMed ID: 37767605 [Abstract] [Full Text] [Related]
16. Fetal growth velocity and body proportion in the assessment of growth. Hiersch L, Melamed N. Am J Obstet Gynecol; 2018 Feb 01; 218(2S):S700-S711.e1. PubMed ID: 29422209 [Abstract] [Full Text] [Related]
17. Development and validation of prediction models for fetal growth restriction and birthweight: an individual participant data meta-analysis. Allotey J, Archer L, Coomar D, Snell KI, Smuk M, Oakey L, Haqnawaz S, Betrán AP, Chappell LC, Ganzevoort W, Gordijn S, Khalil A, Mol BW, Morris RK, Myers J, Papageorghiou AT, Thilaganathan B, Da Silva Costa F, Facchinetti F, Coomarasamy A, Ohkuchi A, Eskild A, Arenas Ramírez J, Galindo A, Herraiz I, Prefumo F, Saito S, Sletner L, Cecatti JG, Gabbay-Benziv R, Goffinet F, Baschat AA, Souza RT, Mone F, Farrar D, Heinonen S, Salvesen KÅ, Smits LJ, Bhattacharya S, Nagata C, Takeda S, van Gelder MM, Anggraini D, Yeo S, West J, Zamora J, Mistry H, Riley RD, Thangaratinam S. Health Technol Assess; 2024 Aug 01; 28(47):1-119. PubMed ID: 39252507 [Abstract] [Full Text] [Related]
18. Obstetrical complications associated with abnormal maternal serum markers analytes. Gagnon A, Wilson RD, SOCIETY OF OBSTETRICIANS AND GYNAECOLOGISTS OF CANADA GENETICS COMMITTEE. J Obstet Gynaecol Can; 2008 Oct 01; 30(10):918-932. PubMed ID: 19038077 [Abstract] [Full Text] [Related]
19. Definition and management of fetal growth restriction: a survey of contemporary attitudes. Unterscheider J, Daly S, Geary MP, Kennelly MM, McAuliffe FM, O'Donoghue K, Hunter A, Morrison JJ, Burke G, Dicker P, Tully EC, Malone FD. Eur J Obstet Gynecol Reprod Biol; 2014 Mar 01; 174():41-5. PubMed ID: 24360357 [Abstract] [Full Text] [Related]
20. Is cerebroplacental ratio a marker of impaired fetal growth velocity and adverse pregnancy outcome? Khalil A, Morales-Rosello J, Khan N, Nath M, Agarwal P, Bhide A, Papageorghiou A, Thilaganathan B. Am J Obstet Gynecol; 2017 Jun 01; 216(6):606.e1-606.e10. PubMed ID: 28189607 [Abstract] [Full Text] [Related] Page: [Next] [New Search]